Trademark applications and grants for Medivir Ab. Medivir Ab has 4 trademark applications. The latest application filed is for "MEDIVIR"
Patent Application | Date |
---|---|
METHODS FOR TREATING LIVER CANCERS USING AN ORALLY ADMINISTERED DIOXOLANE NUCLEOTIDE IN COMBINATION WITH AN ANTI-PD1 OR ANTI-PDL1 MONOCLONAL ANTIBODY 20220117983 - 17/431686 ALBERTELLA; Mark | 2022-04-21 |
Base-Modified Cytidine Nucleotides for Leukemia Therapy 20210261584 - 17/254099 PINHO; Pedro ;   et al. | 2021-08-26 |
DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER 20210054008 - 17/087483 BETHELL; Richard ;   et al. | 2021-02-25 |
Pharmaceutical Formulation for Histone Deacetylase Inhibitors 20210038555 - 16/924591 Chappell; Todd W. ;   et al. | 2021-02-11 |
PROTEASE INHIBITORS 20210017140 - 16/940067 ODEN; Lourdes Salvador ;   et al. | 2021-01-21 |
Dioxolane analogues of uridine for the treatment of cancer 11,447,511 - 17/087,483 Bethell , et al. September 20, 2 | 2022-09-20 |
Dioxolane analogues of uridine for the treatment of cancer 11,447,511 - 17/087,483 Bethell , et al. September 20, 2 | 2022-09-20 |
SMAC mimetic 11,351,221 - 16/783,481 Condon , et al. June 7, 2 | 2022-06-07 |
SMAC mimetic 11,351,221 - 16/783,481 Condon , et al. June 7, 2 | 2022-06-07 |
Protease inhibitors 11,312,693 - 16/940,067 Oden , et al. April 26, 2 | 2022-04-26 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"MEDIVIR" 4605082 86189021 |
MEDIVIR 2014-02-10 |
"XERCLEAR" 3805983 77812821 |
XERCLEAR 2009-08-26 |
"LIPSOVIR" 79004432 |
LIPSOVIR 2004-04-02 |
"LIPSOVIR" 3041863 79002304 |
LIPSOVIR 2004-04-02 |
SEC | 0001573866 | Medivir AB/ADR |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.